Log In
Print this Print this

Lyme disease vaccine

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionMultivalent recombinant outer surface protein A (OspA) Lyme Borreliosis vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationLyme disease
Indication DetailsPrevent Lyme disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today